UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 3,911 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• UBS Asset Management increased its stake in GE HealthCare Technologies by 0.1% in Q1, owning approximately 3.3 million shares valued at $268.7 million.
• A recent report from Zacks Research upgraded the company from a "hold" to a "strong-buy" rating, reflecting positive analyst sentiment and a consensus rating of "Moderate Buy."
• The company reported a net margin of 11.22% and beat earnings estimates with $1.06 per share, driving a 3.5% increase in revenue compared to the previous year.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,329,007 shares of the company's stock after buying an additional 3,911 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.73% of GE HealthCare Technologies worth $268,684,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. Hotchkis & Wiley Capital Management LLC grew its position in shares of GE HealthCare Technologies by 3.2% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company's stock valued at $464,226,000 after acquiring an additional 176,572 shares during the period. JPMorgan Chase & Co. lifted its stake in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in GE HealthCare Technologies by 3.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company's stock valued at $398,975,000 after purchasing an additional 157,839 shares during the period. Canada Pension Plan Investment Board increased its position in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company's stock worth $251,121,000 after buying an additional 409,636 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of GE HealthCare Technologies by 3.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company's stock valued at $247,708,000 after buying an additional 109,858 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on GEHC shares. Morgan Stanley dropped their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock traded down $1.52 during trading on Friday, hitting $76.44. The stock had a trading volume of 3,254,120 shares, compared to its average volume of 2,952,966. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm has a market cap of $34.90 billion, a price-to-earnings ratio of 15.66, a P/E/G ratio of 2.98 and a beta of 1.13. The business's 50-day moving average is $74.46 and its 200 day moving average is $73.54.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same period in the previous year, the business earned $1.00 earnings per share. The firm's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.